首页|替诺福韦与齐多夫定两种治疗方案对艾滋病患者的疗效研究

替诺福韦与齐多夫定两种治疗方案对艾滋病患者的疗效研究

扫码查看
目的:探讨替诺福韦和齐多夫定两种方案治疗艾滋病的临床效果。方法:回顾性分析我院2019 年 10 月—2022年 1 月收治的 83 例艾滋病患者作为研究对象。根据抗病毒药物方案的不同将患者分为A组 45 例和B组 38 例。A组实施以替诺福韦为主的治疗方案,B组实施以齐多夫定为主的治疗方案,比较两组的治疗效果。结果:A组治疗后 3、6 个月HIV-RNA病毒载量均低于B组,差异有统计学意义(P<0。05);A组治疗后 3、6 个月外周血液中CD4+T淋巴细胞计数高于B组,差异有统计学意义(P<0。05);A组治疗后 6 个月SF-36 评分高于B组,SAS、SDS评分低于B组,差异有统计学意义(P<0。05);A组不良反应发生率为 8。89%,低于B组的 31。58%,差异有统计学意义(P<0。05)。结论:以替诺福韦为主的抗病毒药物治疗艾滋病的效果确切,可抑制患者体内的病毒载量,改善免疫水平,提升生活质量,降低不良情绪,且安全性良好。
Study on Efficacy of Tenofovir and Zidovudine in AIDS Patients
Objective:To investigate the clinical effect of tenofovir and zidovudine in the treatment of AIDS.Methods:A retrospective analysis of 83 AIDS patients admitted to our hospital from October 2019 to January 2022 was conducted as the research object.The patients were divided into group A(45 cases)and group B(38 cases)according to different antiviral regimens.Group A was treated with tenofovir-based treatment,and group B was treated with zidovudine-based treatment.The therapeutic effects of the two groups were compared.Results:The HIV-RNA viral load in group A was lower than that in group B at 3 and 6 months after treatment,and the difference was statistically significant(P<0.05).The peripheral blood CD4+T lymphocyte count in group A was higher than that in group B at 3 and 6 months after treatment,the difference was statistically significant(P<0.05).The SF-36 score of group A was higher than that of group B at 6 months after treatment,and the SAS and SDS scores were lower than those of group B,the difference was statistically significant(P<0.05).The incidence of adverse reactions in group A was 8.89%,which was lower than 31.58%in group B,the difference was statistically significant(P<0.05).Conclusion:Tenofovir-based antiviral drugs are effective in the treatment of AIDS,which can inhibit the viral load in patients,improve immune level,improve quality of life,reduce bad mood,and have good safety.

AIDSTenofovirZidovudineAdverse reactions

顾杨、傅斌红

展开 >

邵武市立医院,福建 邵武 354099

艾滋病 替诺福韦 齐多夫定 不良反应

2024

中国药物滥用防治杂志
中国药物滥用防治协会 军事医学科学院毒物药物研究所

中国药物滥用防治杂志

影响因子:0.584
ISSN:1006-902X
年,卷(期):2024.(1)
  • 8